Five-year real-world data on fingolimod treatment's effects on cognitive function

ÖZAKBAŞ S., Piri Cinar B., Yigit P., Baba C., Sagici O.

Multiple Sclerosis and Related Disorders, vol.54, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 54
  • Publication Date: 2021
  • Doi Number: 10.1016/j.msard.2021.103089
  • Journal Name: Multiple Sclerosis and Related Disorders
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Keywords: Multiple sclerosis, Fingolimod, Cognition, REMITTING MULTIPLE-SCLEROSIS, PLACEBO-CONTROLLED TRIAL, ORAL FINGOLIMOD, INTERFERON, MS, MULTICENTER, NATALIZUMAB, IMPAIRMENT, RELEVANCE, EFFICACY
  • Dokuz Eylül University Affiliated: Yes